• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Childhood Cancer Survivors: Screening Little Hearts for Big Problems.

作者信息

Chen Ming Hui

机构信息

Departments of Cardiology and Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

出版信息

JACC CardioOncol. 2020 Mar 17;2(1):38-40. doi: 10.1016/j.jaccao.2020.02.015. eCollection 2020 Mar.

DOI:10.1016/j.jaccao.2020.02.015
PMID:34396207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352172/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c6/8352172/0a666d819a85/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c6/8352172/0a666d819a85/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c6/8352172/0a666d819a85/fx1.jpg

相似文献

1
Childhood Cancer Survivors: Screening Little Hearts for Big Problems.儿童癌症幸存者：筛查小心脏中的大问题。
JACC CardioOncol. 2020 Mar 17;2(1):38-40. doi: 10.1016/j.jaccao.2020.02.015. eCollection 2020 Mar.
2
Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future.儿童癌症幸存者的心肌病：过去的经验教训与未来的挑战
Curr Oncol Rep. 2016 Apr;18(4):22. doi: 10.1007/s11912-016-0510-4.
3
Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial.增加对儿科恶性肿瘤成年幸存者的心肌病筛查：一项随机对照试验。
J Clin Oncol. 2014 Dec 10;32(35):3974-81. doi: 10.1200/JCO.2014.57.3493. Epub 2014 Nov 3.
4
Childhood Cancer Survivors' Reported Late Effects, Motivations for Seeking Survivorship Care, and Patterns of Attendance.儿童癌症幸存者报告的晚期效应、寻求生存护理的动机以及就诊模式。
Oncologist. 2023 May 8;28(5):e276-e286. doi: 10.1093/oncolo/oyad004.
5
Emerging and Ongoing Survivorship Challenges Among Childhood Cancer Survivors and Providing Risk-Based Focused Follow-Up Care.儿童癌症幸存者的新出现和持续生存挑战，以及提供基于风险的重点随访护理。
Semin Oncol Nurs. 2021 Jun;37(3):151163. doi: 10.1016/j.soncn.2021.151163. Epub 2021 Jun 16.
6
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.筛查成年癌症幸存者的心肌病：超声心动图与心脏磁共振成像的比较。
J Clin Oncol. 2012 Aug 10;30(23):2876-84. doi: 10.1200/JCO.2011.40.3584. Epub 2012 Jul 16.
7
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy.德尔菲专家小组关于筛查和管理有心肌病风险的儿童癌症幸存者的共识建议。
JACC CardioOncol. 2022 Aug 16;4(3):354-367. doi: 10.1016/j.jaccao.2022.05.010. eCollection 2022 Sep.
8
Models of childhood cancer survivorship care in Australia and New Zealand: Strengths and challenges.澳大利亚和新西兰儿童癌症幸存者护理模式：优势与挑战。
Asia Pac J Clin Oncol. 2017 Dec;13(6):407-415. doi: 10.1111/ajco.12700. Epub 2017 Jul 3.
9
A Collaborative Step-Wise Process to Implementing an Innovative Clinic for Adult Survivors of Childhood Cancer.一个用于为儿童癌症成年幸存者建立创新诊所的协作式逐步流程。
J Pediatr Nurs. 2015 Sep-Oct;30(5):e147-55. doi: 10.1016/j.pedn.2015.05.026. Epub 2015 Jul 20.
10
Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer.参加专门的幸存者诊所可提高儿童癌症成年幸存者对心肌病筛查指南的依从性。
J Cancer Surviv. 2017 Oct;11(5):614-623. doi: 10.1007/s11764-017-0634-z. Epub 2017 Aug 7.

本文引用的文献

1
Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors.儿童癌症幸存者心脏功能超声心动图参数的纵向变化
JACC CardioOncol. 2020 Mar;2(1):26-37. doi: 10.1016/j.jaccao.2020.02.016. Epub 2020 Mar 17.
2
The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work Group.儿科癌症患者及其幸存者的心血管护理现状：美国心脏病学会儿科心脏肿瘤学工作组的一项调查
Cardiooncology. 2019 Oct 23;5:16. doi: 10.1186/s40959-019-0051-8. eCollection 2019.
3
Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
超声心动图评估蒽环类药物治疗儿童癌症后幸存者的心脏功能。
Circ Cardiovasc Imaging. 2019 Dec;12(12):e008869. doi: 10.1161/CIRCIMAGING.119.008869. Epub 2019 Dec 12.
4
Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association.儿童心肌病：分类与诊断——美国心脏协会科学声明
Circulation. 2019 Jul 2;140(1):e9-e68. doi: 10.1161/CIR.0000000000000682. Epub 2019 May 28.
5
Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.超声心动图在癌症治疗期间和治疗后患者临床决策中的当代作用。
JACC Cardiovasc Imaging. 2018 Aug;11(8):1122-1131. doi: 10.1016/j.jcmg.2018.03.025.
6
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.成人癌症幸存者心功能障碍的预防和监测：美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2017 Mar 10;35(8):893-911. doi: 10.1200/JCO.2016.70.5400. Epub 2016 Dec 5.
7
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.儿童肿瘤协作组（COG）研究ALTE1621的原理与设计：一项随机、安慰剂对照试验，旨在确定低剂量卡维地洛能否预防有发生心力衰竭高风险的儿童癌症幸存者出现蒽环类药物相关的左心室重塑。
BMC Cardiovasc Disord. 2016 Oct 4;16(1):187. doi: 10.1186/s12872-016-0364-6.
8
Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.接受心脏毒性治疗的儿童癌症成年幸存者的心脏结局：一项横断面研究。
Ann Intern Med. 2016 Jan 19;164(2):93-101. doi: 10.7326/M15-0424. Epub 2016 Jan 5.
9
Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.儿童癌症成年幸存者治疗相关心脏功能障碍的综合超声心动图检测：圣裘德终身队列研究结果
J Am Coll Cardiol. 2015 Jun 16;65(23):2511-22. doi: 10.1016/j.jacc.2015.04.013.
10
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.儿童癌症幸存者心肌病监测建议：国际儿童癌症长期效应指南协调小组报告
Lancet Oncol. 2015 Mar;16(3):e123-36. doi: 10.1016/S1470-2045(14)70409-7.